Early Findings of Computed Tomography and Angiography in Acute Stroke and Thrombolytic Therapy

Before thrombolytic treatment in acute stroke, a computed tomographic (CT) scan is necessary to exclude brain hemorrhage and other causes of focal neurological deficit imitating cerebral ischemia. Angiographic demonstration of arterial occlusion is a precondition for local intraarterial infusion of thrombolytics. At present, several major clinical trials testing the effect of intravenous thrombolytic treatment in acute stroke are conducted without the information of initial angiography so as to gain time for early treatment [1–3]. So far, there are only a few reports available concerning the significance of CT scan and angiography for thrombolytic treatment [4–7]. We studied the question whether positive signs of cerebral ischemia in CT scan such as parenchymal hypodensity and focal brain swelling, together with the angiographically proved site of arterial occlusion and state of collateral blood supply, have predictive value for arterial recanalization and clinical outcome in hemispheric stroke. The significance of angiography in basilar artery occlusion is reported elsewhere in these proceedings (See Chapter, “Thrombolytic Therapy of Basilar Artery Occlusion: Preconditions for Recanalization and Good Clinical Outcome,” in this volume). Data of subgroups of patients reported here have been published previously [8–10].

[1]  Lippincott Williams Wilkins,et al.  Multicenter Trial of Hemodilution in Ischemic Stroke — Background and Study Protocol , 1985, Stroke.

[2]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[3]  A. Yamadori,et al.  Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. , 1988, Stroke.

[4]  A. Bozzao,et al.  Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. , 1989, Stroke.

[5]  W. Hacke,et al.  Safety and Efficacy of Intravenous Tissue Plasminogen Activator and Heparin in Acute Middle Cerebral Artery Stroke , 1992, Stroke.

[6]  C. Weiller,et al.  Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization , 1992, Neurology.

[7]  W. Hacke,et al.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.

[8]  W. Hacke,et al.  Thrombolytic Therapy in Acute Ischemic Stroke II , 1993, Springer Berlin Heidelberg.

[9]  D. Krieger,et al.  The Prognostic Value of Collateral Blood Flow in Acute Middle Cerebral Artery Occlusion , 1993 .

[10]  W. Hacke Thrombolysis: Stroke Subtype and Embolus Type , 1993 .

[11]  T. Brott Symptom-Based Trials of Intravenous rt-PA in Acute Stroke , 1993 .

[12]  G. Hankey,et al.  Australian Streptokinase Trial (ASK) , 1993 .

[13]  M. Pessin,et al.  Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. , 1993, AJNR. American journal of neuroradiology.

[14]  M. Forsting,et al.  Effects of Recanalization and Collateral Blood Supply on Infarct Extent and Brain Edema after Middle Cerebral Artery Occlusion , 1993 .

[15]  M. Kaste,et al.  The European Cooperative Acute Stroke Study (ECASS) , 1993 .

[16]  W Hacke,et al.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. , 1994, AJNR. American journal of neuroradiology.